SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, ND
Recalled January 14, 2026 · FDA recall D-0254-2026 · SpecGx
Hazard
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. · FDA Class II
Units
287,988 Bottles.
Sold at
Nationwide
Description
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Product
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Manufacturer(s)
SpecGx, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →